Study: Chang 2022, Journal of the National Cancer Institute

Use of Straighteners and Other Hair Products and Incident Uterine Cancer

Citation

Chang CJ, O'Brien KM, Keil AP, Gaston SA et al (2022). Journal of the National Cancer Institute. PubMed id 36245087.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Chemical relaxers and hair straighteners Tier B moderate

    B 33,947 US women aged 35-74 in the Sister Study (racially and ethnically diverse) (n=33947)

    Prospective cohort, average 10.9 years; 378 uterine cancers.

    Ever use of straightening products in the previous year was associated with higher uterine cancer rates (hazard ratio 1.80, 95% CI 1.12-2.88); more than 4 uses in the previous year, 2.55 (1.46-4.45). Dyes and perms were not associated. The authors call it the first epidemiological evidence of this link and say more research is warranted.

    As recorded in this card: Chang CJ, O'Brien KM, Keil AP, Gaston SA et al (2022), Journal of the National Cancer Institute, [primary]

    Note: Mixed-race cohort; the abstract does not break the result out by race. Self-reported use in the prior 12 months.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.